X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare TTK HEALTHCARE with WYETH LTD - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TTK HEALTHCARE vs WYETH LTD - Comparison Results

WYETH LTD 
   Change

Wyeth Limited is the 51% subsidiary of Wyeth, US and is the sixth largest company among multinationals with revenues of Rs 2.9 bn in FY07. The company derives its revenues from pharmaceutical and OTC segments with focus on various therapeutic areas s... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    TTK HEALTHCARE WYETH LTD TTK HEALTHCARE/
WYETH LTD
 
P/E (TTM) x 18.5 27.7 66.7% View Chart
P/BV x 4.7 5.3 88.6% View Chart
Dividend Yield % 0.6 1.3 48.1%  

Financials

 TTK HEALTHCARE   WYETH LTD
EQUITY SHARE DATA
    TTK HEALTHCARE
Mar-14
WYETH LTD
Mar-13
TTK HEALTHCARE/
WYETH LTD
5-Yr Chart
Click to enlarge
High Rs6631,044 63.5%   
Low Rs399818 48.8%   
Sales per share (Unadj.) Rs535.6298.6 179.4%  
Earnings per share (Unadj.) Rs15.957.2 27.9%  
Cash flow per share (Unadj.) Rs20.058.4 34.3%  
Dividends per share (Unadj.) Rs4.0017.00 23.5%  
Dividend yield (eoy) %0.81.8 41.2%  
Book value per share (Unadj.) Rs137.6249.5 55.2%  
Shares outstanding (eoy) m7.7722.72 34.2%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.03.1 31.8%   
Avg P/E ratio x33.316.3 204.8%  
P/CF ratio (eoy) x26.515.9 166.4%  
Price / Book Value ratio x3.93.7 103.4%  
Dividend payout %25.129.7 84.5%   
Avg Mkt Cap Rs m4,12721,157 19.5%   
No. of employees `0001.70.5 347.2%   
Total wages/salary Rs m607400 151.7%   
Avg. sales/employee Rs Th2,436.713,787.4 17.7%   
Avg. wages/employee Rs Th355.2813.0 43.7%   
Avg. net profit/employee Rs Th72.52,643.3 2.7%   
INCOME DATA
Net Sales Rs m4,1626,783 61.4%  
Other income Rs m61353 17.4%   
Total revenues Rs m4,2237,136 59.2%   
Gross profit Rs m1971,617 12.2%  
Depreciation Rs m3227 119.2%   
Interest Rs m306 543.6%   
Profit before tax Rs m1971,938 10.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-5 0.0%   
Tax Rs m73632 11.5%   
Profit after tax Rs m1241,301 9.5%  
Gross profit margin %4.723.8 19.9%  
Effective tax rate %37.032.6 113.4%   
Net profit margin %3.019.2 15.5%  
BALANCE SHEET DATA
Current assets Rs m1,6296,984 23.3%   
Current liabilities Rs m1,0582,056 51.5%   
Net working cap to sales %13.772.6 18.9%  
Current ratio x1.53.4 45.3%  
Inventory Days Days3099 30.0%  
Debtors Days Days3424 140.3%  
Net fixed assets Rs m556244 227.7%   
Share capital Rs m78227 34.2%   
"Free" reserves Rs m8785,441 16.1%   
Net worth Rs m1,0695,668 18.9%   
Long term debt Rs m15925 634.8%   
Total assets Rs m2,3997,901 30.4%  
Interest coverage x7.6353.3 2.1%   
Debt to equity ratio x0.10 3,364.9%  
Sales to assets ratio x1.70.9 202.0%   
Return on assets %6.416.5 38.8%  
Return on equity %11.622.9 50.5%  
Return on capital %18.534.0 54.2%  
Exports to sales %0.80.2 362.3%   
Imports to sales %1.436.3 3.9%   
Exports (fob) Rs m3315 222.3%   
Imports (cif) Rs m582,465 2.4%   
Fx inflow Rs m3315 216.4%   
Fx outflow Rs m632,677 2.4%   
Net fx Rs m-30-2,662 1.1%   
CASH FLOW
From Operations Rs m127923 13.7%  
From Investments Rs m-146317 -46.1%  
From Financial Activity Rs m22-481 -4.6%  
Net Cashflow Rs m3759 0.3%  

Share Holding

Indian Promoters % 65.4 0.0 -  
Foreign collaborators % 0.0 51.1 -  
Indian inst/Mut Fund % 3.7 11.3 32.7%  
FIIs % 5.2 7.2 72.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.8 30.4 84.9%  
Shareholders   12,723 21,978 57.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare TTK HEALTHCARE With:   AUROBINDO PHARMA  MERCK LTD  GSK PHARMA  FULFORD INDIA  ORCHID PHARMA LTD  

Compare TTK HEALTHCARE With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Recapitalisation Package for PSBs: The Pros & Cons(Podcast)

Corporate governance issues with certain companies, uncertainty surrounding national elections and global issues like trade wars, Brexit, have taken a toll on the Indian markets.

Related Views on News

TTK HEALTHCARE Announces Quarterly Results (3QFY19); Net Profit Down 60.1% (Quarterly Result Update)

Feb 1, 2019 | Updated on Feb 1, 2019

For the quarter ended December 2018, TTK HEALTHCARE has posted a net profit of Rs 49 m (down 60.1% YoY). Sales on the other hand came in at Rs 1 bn (up 2.1% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

TTK HEALTHCARE Announces Quarterly Results (2QFY19); Net Profit Down 15.3% (Quarterly Result Update)

Nov 12, 2018 | Updated on Nov 12, 2018

For the quarter ended September 2018, TTK HEALTHCARE has posted a net profit of Rs 67 m (down 15.3% YoY). Sales on the other hand came in at Rs 2 bn (up 16.3% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

TTK HEALTHCARE Announces Quarterly Results (1QFY19); Net Profit Down 276.0% (Quarterly Result Update)

Aug 13, 2018 | Updated on Aug 13, 2018

For the quarter ended June 2018, TTK HEALTHCARE has posted a net profit of Rs 79 m (down 276.0% YoY). Sales on the other hand came in at Rs 2 bn (up 38.1% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

TTK HEALTHCARE Announces Quarterly Results (4QFY18); Net Profit Up 43.1% (Quarterly Result Update)

Jun 14, 2018 | Updated on Jun 14, 2018

For the quarter ended March 2018, TTK HEALTHCARE has posted a net profit of Rs 80 m (up 43.1% YoY). Sales on the other hand came in at Rs 1 bn (up 21.4% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

More Views on News

Most Popular

The One Real Estate Stock to Buy Now(The 5 Minute Wrapup)

Feb 13, 2019

The real estate sector is ready to make a comeback. This is the stock to consider buying.

Don't Be Afraid of the Market; Buy Stocks Like This One(The 5 Minute Wrapup)

Feb 14, 2019

During this tough period in the market, a contrarian approach holds huge potential upside for this Smart Money Secrets stock.

Small Caps Under Seige: Could This Be A Once-in-a-Decade Wealth Creating Opportunity?(Profit Hunter)

Feb 14, 2019

Don't let the dark clouds hovering over small caps scare you into hiding; it will rain gold as sentiments recover. Indeed, there is a blood bath. And if you are a first time investor, the correction is deep enough to scare you out of markets.

The 4-Point Plan to Accelerate India to a 10 Trillion Dollar Economy(The 5 Minute Wrapup)

Feb 12, 2019

Two questions I have been eagerly waiting to ask you ever since Budget 2019 was announced.

The Train to 'Small-Cap-Profits Land' is Back on the Station!(Profit Hunter)

Feb 15, 2019

Why its great news that prices for small caps over the last few days have been falling like there's no tomorrow.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

TTK HEALTHCARE SHARE PRICE


Feb 22, 2019 (Close)

TRACK TTK HEALTHCARE

  • Track your investment in TTK HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TTK HEALTHCARE

TTK HEALTHCARE - ALKEM LABORATORIES COMPARISON

COMPARE TTK HEALTHCARE WITH

MARKET STATS